IP Library Patent Application 13262286
Patent Application
App. No. 13/262,286

DECELLULARIZATION AND RECELLULARIZATION OF ORGANS AND TISSUES

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/262,286
Abstract

The invention provides for methods and materials to decellularize an organ or portion thereof and to recellularize such a decellularized organ or portion thereof to thereby generate an organ or portion thereof.

Claims (25)

1 . A method of making a liver, comprising

providing a decellularized liver, wherein said decellularized liver comprises a decellularized extracellular matrix of said liver, wherein said extracellular matrix comprises an exterior surface, and wherein said extracellular matrix, including the vascular tree, substantially retains the morphology of said extracellular matrix prior to decellularization, and wherein said exterior surface is substantially intact; and

contacting said decellularized liver with about 40,000 or more regenerative cells under conditions in which said cells engraft, multiply and/or differentiate within and on said decellularized liver.

2 . The method of claim 1 , wherein said decellularized liver is contacted with about 23 million or more regenerative cells.

3 . The method of claim 1 , wherein said decellularized liver is contacted with about 30 million or more regenerative cells.

4 . The method of claim 1 , wherein said decellularized liver is contacted with about 35 million or more regenerative cells.

5 . The method of claim 1 , wherein said regenerative cells are hepatocytes.

6 . The method of claim 1 , wherein said regenerative cells are infused into said decellularized liver via a portal vein.

7 . The method of claim 1 , wherein said regenerative cells are injected into said decellularized liver.

8 . A method of making a liver lobe, comprising

providing a decellularized liver or lobe-containing portion thereof, wherein said decellularized liver or lobe-containing portion thereof comprises a decellularized extracellular matrix of said liver or lobe-containing portion thereof, wherein said extracellular matrix comprises an exterior surface, and wherein said extracellular matrix, including the vascular tree, substantially retains the morphology of said extracellular matrix prior to decellularization, and wherein said exterior surface is substantially intact; and

contacting a lobe of said decellularized liver or lobe-containing portion thereof with a population of regenerative cells under conditions in which said regenerative cells engraft, multiply and/or differentiate within and on said decellularized liver lobe.

9 . The method of claim 8 , wherein said regenerative cells are primary hepatocytes.

10 . The method of claim 8 , wherein said regenerative cells are infused into said lobe via a portal vein.

11 . A method of decellularizing an organ, comprising:

providing said organ;

cannulating said organ at one or more cavities, vessels, and/or ducts, thereby producing a cannulated organ;

perfusing said cannulated organ with a first cellular disruption medium via said one or more cannulations; and

determining the amount of nucleic acid remaining in the decellularized organ as compared to a corresponding cadaveric organ.

12 . The method of claim 11 , wherein said perfusing is for about 2 to 12 hours per gram of organ tissue.

13 . The method of claim 11 , wherein said perfusing step is continued until there is 5% or less nucleic acid remaining in the decellularized organ.

14 . The method of claim 11 , wherein said cellular disruption medium comprises 1% SDS.

15 . The method of claim 11 , wherein said perfusion is multi-directional from each cannulated cavity, vessel, and/or duct.

16 . A decellularized mammalian adrenal gland, comprising

a decellularized extracellular matrix of said adrenal gland, wherein said extracellular matrix comprises an exterior surface, and wherein said extracellular matrix, including the vascular tree, substantially retains the morphology of said extracellular matrix prior to decellularization, and wherein said exterior surface is substantially intact.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 6, 2018
From: TAYLOR, DORIS; OTT, HARALD
To: REGENTS OF THE UNIVERSITY OF MINNESOTA
Reel/Frame 046002/0541 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 8, 2016
From: REGENTS OF THE UNIVERSITY OF MINNESOTA
To: MIROMATRIX MEDICAL INC.
Reel/Frame 040254/0103 →